FVE calls for a real debate on “Microbial Challenge – Rising threats from antimicrobial resistance”
Tuesday, 04 December 2012
Decoupling prescription from sales – which is not supported by any impact assessment – is not the right answer.
Christophe Buhot, President of the FVE emphasises that “the FVE continues to be concerned about the growing incidence of infections caused by multi-drug resistant bacteria. The FVE has taken several initiatives to contain the emergence and spread of resistant bacteria: disease prevention, promotion of responsible use of medicines, recordkeeping, and monitoring of the occurrence of resistance are cornerstones of FVE’s strategy”.
He also adds “There is indeed no clear evidence from differences in amounts of antibiotics used between countries that have and that haven’t decoupled”.